Ignite Creation Date:
2024-05-06 @ 11:10 AM
Last Modification Date:
2024-10-26 @ 12:41 PM
Study NCT ID:
NCT03449381
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-30
First Post:
2018-02-12
Brief Title:
This Study Aims to Find the Best Dose of BI 907828 Brigimadlin in Patients With Different Types of Advanced Cancer Solid Tumors
Sponsor:
Organization:
Boehringer Ingelheim